FDA Clears First Fully Automated Calprotectin Test for IBD Diagnosis, Inova Says

FDA Clears First Fully Automated Calprotectin Test for IBD Diagnosis, Inova Says
The U.S. Food and Drug Administration (FDA) has approved the QUANTA Flash Calprotectin test to help diagnose inflammatory bowel disease (IBD) and differentiate that disease from irritable bowel syndrome (IBS). Developed by Inova Diagnostics, QUANTA Flash Calprotectin is the first fully automated, random access calprotectin assay given FDA approval. The test is an immunoassay designed to detect

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *